Biopharmaceutical company.
Monitored legislative efforts to reform the corporate tax system. H.R. 3309: Innovation Act. Education and outreach regarding proposed legislation to promote HCV testing.

Monitored implementation of Affordable Care Act as it relates to a regulatory for biosimilars. Education and outreach about the competitive elements of the Medicare Part D drug benefit and opposition to legislation imposing Medicaid style manufacturer rebates in the program.

H.R. 2810, S.: Medicare Patient Access and Quality Improvement Act of 2013 H.J. Res. 59  The Bipartisan Budget Act of 2013 Public Law No: 113-067.
TAX - Taxation/Internal Revenue Code CPT - Copyright/Patent/Trademark HCR - Health Issues MMM - Medicare/Medicaid BUD - Budget/Appropriations
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
W STRATEGIES, LLC
1455 Pennsylvania Avenue, NW, Suite 400, Washington, DC, 20004, US
DARREN WILLCOX DARREN WILLCOX DARREN WILLCOX DARREN WILLCOX DARREN WILLCOX